CNBC March 6, 2025
Annika Kim Constantino

Key Points

– Walgreens said it inked a deal with private equity firm Sycamore Partners that will take it off the public market for an equity value of around $10 billion.

– The historic transaction ends Walgreens’ tumultuous run as a public company, which began in 1927.

– Walgreens has been squeezed by the transition out of the Covid pandemic, pharmacy reimbursement headwinds, softer consumer spending and a troubled push into healthcare.

Struggling drugstore chain Walgreens is going private.

The company on Thursday said it inked a deal with private equity firm Sycamore Partners that will take it off the public market for an equity value of around $10 billion.

Sycamore will pay $11.45 per share in cash for...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Investments, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
Related Articles:
The Weapons of Getting Paid: Bringing Data, Technology, and Advocacy to the Battle
Will Trump Drug Tariffs Help Or Hurt The U.S.?
Johnson & Johnson Discontinues Pivotal Depression Drug Trial Due to Lack of Efficacy
Walgreens To Be Acquired By PE Firm Sycamore Partners Amid Shift In Health Care Strategy
First-in-Class Brain Cancer Drug Strikes a Chord With Jazz Pharma to the Tune of a $935M M&A Deal

Share This Article